SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending due to its exceptionally dedicated community relentlessly building a "permissionless brand" with numerous real-world products and initiatives. This strong conviction and consistent development are maintaining a solid floor and driving conversation, even amid challenging market conditions.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending due to the FDA's escalated scrutiny and a Department of Justice referral regarding its compounded GLP-1 weight-loss drugs, sparking a heated debate among investors about the company's compliance versus its mission to disrupt big pharma ahead of a planned Super Bowl advertisement.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST CRYPTO is a top trending Solana privacy project, gaining traction for its utility, fully circulated token supply, and integration with Zebec to drive real-world protocol usage with revenue share for holders. Amidst broader market downturns, the community highlights its resilience and low market cap as a compelling early-stage opportunity.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly Group is trending due to upcoming Q4 earnings anticipated to confirm profitability, fueling community debate around its potential China strategic moves and overall turnaround in the plant-based sector, further supported by recent analyst price target updates and a notable decline in short interest.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing strong momentum following its impressive earnings and optimistic guidance, propelled by robust demand for its optical components essential for AI data center build-outs. The market is actively discussing numerous analyst upgrades and the potential for S&P 500 index inclusion, while also weighing concerns about the stock's accelerated valuation.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is gaining attention following its agreement with the U.S. Army for advanced manufacturing, with the community enthusiastically highlighting its critical role in defense and aerospace supply chains through partnerships with SpaceX and active discussions with Anduril.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amidst an FDA crackdown on compounded GLP-1 drugs, which is seen as a significant positive for legitimate biotechs in the obesity market. The community is actively discussing Viking's best-in-class GLP-1/GIP agonist, VK2735, believing it positions the company as a prime acquisition target for major pharma seeking to compete with market leaders like Eli Lilly after Novo Nordisk's recent sales struggles.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is buzzing with its community actively preparing for the upcoming 4/20 cultural event, championing its mission to destigmatize cannabis and integrate real-world utility under the rallying cry "Like Bitcoin but way higher." Community discussions highlight its culture-first approach, valuing patience and shared progress in the evolving crypto and cannabis space.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is trending as its Eversense 365, the world's first one-year implantable continuous glucose monitor, secured European CE Mark approval and began commercial integration with an automated insulin delivery system. Despite strong community belief in the product's superior, long-lasting technology for diabetes management, investors remain vocal about perceived management execution issues and actively speculate on potential acquisition interest.

DigitalOcean Holdings, Inc. engages in the provision of providing cloud infrastructure. It operates through the following geographical segments: United States, Netherlands, Germany, Canada, Singapore, and Other. The company was founded in 2012 and is headquartered in Broomfield, CO.

DigitalOcean Holdings Inc

DigitalOcean is trending due to robust earnings reports and multiple analyst upgrades, with the community actively discussing its position as an undervalued AI cloud infrastructure provider. Its partnerships, including with AMD for AI model training and hosting agentic AI projects, are seen as significant catalysts for potential upside in the rapidly expanding cloud sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ADAPY When a company gives its CFO a fixed “stay-until” date that’s only a few months away, it usually means the board expects a discrete transaction to close inside that window and then won’t need two finance chiefs.

Adaptimmune pushed Gavin Wood’s exit from 31 May to 31 Aug 2025 under a short extension agreement—after which his employment automatically ends .

The footnotes of its 2024 10-K already flagged a cost-cutting restructuring and said Wood would step down once “strategic alternatives” were settled .

While the March-quarter 10-Q warns of “substantial doubt” about going-concern status , the company has not filed—or prepared the paperwork—for a Chapter 11, and it just prepaid part of its Hercules loan, a move lenders seldom allow when a filing is imminent .

Groggok

Kevin Roger

CanadianMoose529

Dieter Hovekamp

Natalie Ward

Mynoma

Baker

Phillip Longacre

John Smith

StockTwits for iOS

Adaptimmune Therapeutics Plc - ADR

$ADAP When a company gives its CFO a fixed “stay-until” date that’s only a few months away, it usually means the board expects a discrete transaction to close inside that window and then won’t need two finance chiefs.

Adaptimmune pushed Gavin Wood’s exit from 31 May to 31 Aug 2025 under a short extension agreement—after which his employment automatically ends .

The footnotes of its 2024 10-K already flagged a cost-cutting restructuring and said Wood would step down once “strategic alternatives” were settled .

While the March-quarter 10-Q warns of “substantial doubt” about going-concern status , the company has not filed—or prepared the paperwork—for a Chapter 11, and it just prepaid part of its Hercules loan, a move lenders seldom allow when a filing is imminent .

Haydenb323

How this plays out:

Bankruptcy scenario: A Chapter 11 process usually runs 6-12 months. Courts, auditors and DIP lenders insist the CFO (or a court-appointed Chief Restructuring Officer) stay well past the petition date to certify budgets, auction terms and SEC reports. A hard-stop contract before year-end would be unusual, and the board would have negotiated a contingency to keep him if the case drags on.

M&amp;A / reverse-merger scenario: The buyer already has a finance team. The target CFO is kept only long enough to sign the next 10-Q (due early August) and hand over the books at closing—exactly the timetable Adaptimmune just set.

Bottom line: The 31 August cut-off reads far more like a retention bridge to an expected deal close than like preparation for a prolonged bankruptcy process.

zed rickel

hikinglover

Alan Brockett

McNastay

comanche

How this plays out:

Bankruptcy scenario: A Chapter 11 process usually runs 6-12 months. Courts, auditors and DIP lenders insist the CFO (or a court-appointed Chief Restructuring Officer) stay well past the petition date to certify budgets, auction terms and SEC reports. A hard-stop contract before year-end would be unusual, and the board would have negotiated a contingency to keep him if the case drags on.

M&A / reverse-merger scenario: The buyer already has a finance team. The target CFO is kept only long enough to sign the next 10-Q (due early August) and hand over the books at closing—exactly the timetable Adaptimmune just set.

Bottom line: The 31 August cut-off reads far more like a retention bridge to an expected deal close than like preparation for a prolonged bankruptcy process.

@Haydenb323 The CFO’s original departure date was set for May 31 but was later extended to August 31. This likely indicates that a deal expected to close by May did not materialize on schedule, requiring the CFO to remain longer to support ongoing negotiations or finalize the transaction. Hopefully, the deal can be completed by the revised date. My wishful thinking 🧐?

StockTwits For Android 

 The CFO’s original departure date was set for May 31 but was later extended to August 31. This likely indicates that a deal expected to close by May did not materialize on schedule, requiring the CFO to remain longer to support ongoing negotiations or finalize the transaction. Hopefully, the deal can be completed by the revised date. My wishful thinking 🧐?